Comparison of Reduction in Intraocular Pressure and Glaucoma drugs between Ahmed Clear Path and a low cost glaucoma drainage device

Outcomes of Ahmed Clear Path vs Aurolab Aqueous Drainage Implant in refractory glaucoma - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/092817

Enrollment

Registered

2025-08-11

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: H401- Open-angle glaucoma

Interventions

Intervention1: Ahmed clear path: non valved Glaucoma drainage device used for lower iop and number of antiglaucoma medications Control Intervention1: Aurolab Aqeueous drainage implant: glaucoma draina

Eligibility

Inclusion criteria

Inclusion criteria: glaucoma with iop more than 21mmhg poorly controlled with maximum medications failed trabeculectomy with significant optic nerve damage and visual field loss due to glaucoma or any glaucoma patients which is high risk for failure for trabeculectomy. Or with significant conjunctival scarring Participants who consent to participate in the study

Exclusion criteria

Exclusion criteria: Patients with no light perception Previous glaucoma drainage devices Corneal abnormalities that precluded accurate IOP readings Uuncontrolled systemic diseases active uveitis, ocular infection

Design outcomes

Primary

Measure	Time frame
REDUCTION IN INTRAOCULAR PRESSURE AND NUMBER OG ANTIGLAUCOMA MEDICATIONSTimepoint: Success rate in both groups at 6 months follow up	—

Secondary

Measure	Time frame
Surgical complicationsTimepoint: 6 months	—

Countries

India

Contacts

Public ContactDisha Chetani

Postgraduate Institute of Medical Education and Research Chandigarh

dr.faisaltt@yahoo.com9914662345

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026